Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04980807 · ClinicalTrials.gov registry record

Observational Study of Neuromuscular Function in CMT Type 1&2 and Healthy Controls

A clinical trial of Charcot Marie Tooth Disease, sponsored by NMD Pharma A/S.

Completed
Registry status
30
Enrollment target
2
Study locations

NCT04980807 is a study of Charcot Marie Tooth Disease that has completed, run by NMD Pharma A/S. The registered enrollment target is 30 participants, below the 2,361-participant average among 7 other Charcot Marie Tooth Disease trials with a reported enrollment target (99% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04980807, a study of Charcot Marie Tooth Disease, has completed, sponsored by NMD Pharma A/S.

COMPLETED
Registry status
30 participants
Enrollment target
2
Study locations

Study Summary

The primary aim of this study is to discover whether patients with CMT type 1 and 2 have neuromuscular junction transmission deficits. The secondary aim is to collect information of different clinical and electrophysiological test procedures to perform possible future clinical trials in CMT patients.

Conditions Studied

Charcot Marie Tooth Disease

Study Locations (2)

Ohio

  • Ohio State University - Columbus

Jutland

  • Aarhus University Hospital - Aarhus

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2021-04-07
Est. Completion 2022-03-03

Sponsor

NMD Pharma A/S

5 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04980807

The ClinicalTrials.gov registry entry for NCT04980807 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,361-participant average among 7 other Charcot Marie Tooth Disease trials with a reported enrollment target (99% lower). The listed sponsor is NMD Pharma A/S, which has 5 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Charcot Marie Tooth Disease appearing as the primary indexed condition, and to 0 interventions.

NCT04980807 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Ohio, Jutland.

Frequently Asked Questions

What is clinical trial NCT04980807 about?

NCT04980807 is a clinical study titled "Observational Study of Neuromuscular Function in CMT Type 1&2 and Healthy Controls". The primary aim of this study is to discover whether patients with CMT type 1 and 2 have neuromuscular junction transmission deficits. The secondary aim is to collect information of different clinical and electrophysiological test procedures to perform possible future clinical trials in CMT patient...

What is the current status of trial NCT04980807?

This trial is currently completed. The enrollment target is 30 participants. The study started on 2021-04-07. Estimated completion is 2022-03-03.

What conditions does trial NCT04980807 study?

This clinical trial studies the following conditions: Charcot Marie Tooth Disease.

Who is sponsoring clinical trial NCT04980807?

This trial is sponsored by NMD Pharma A/S, which has 5 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04980807 being conducted?

This trial has 2 study locations across Ohio, Jutland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Charcot Marie Tooth Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Charcot Marie Tooth Disease

All registered trials for this condition

Ohio

All trials with a study site in Ohio

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.